Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
Clinical trial NCT00348595 · COMPLETED
Trial details
- NCT number
- NCT00348595
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-20
- Primary completion
- 2016-06-29
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.